{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:12:09Z","timestamp":1777371129689,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T00:00:00Z","timestamp":1562112000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T00:00:00Z","timestamp":1562112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s12032-019-1294-9","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T06:48:23Z","timestamp":1562136503000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Functional coding and non-coding variants in human BRCA1 gene and their use in genetic screening"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3332-471X","authenticated-orcid":false,"given":"Gulten","family":"Tuncel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9593-9325","authenticated-orcid":false,"given":"Mahmut \u00c7erkez","family":"Erg\u00f6ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,3]]},"reference":[{"issue":"10","key":"1294_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.tig.2013.04.005","volume":"29","author":"CD Campbell","year":"2013","unstructured":"Campbell CD, Eichler EE. Properties and rates of germline mutations in humans. Trends Genet. 2013;29(10):575\u201384.","journal-title":"Trends Genet"},{"key":"1294_CR2","volume-title":"Somatic versus germinal mutation. An introduction to genetic analysis","author":"AJ Griffiths","year":"2000","unstructured":"Griffiths AJ, et al. Somatic versus germinal mutation. An introduction to genetic analysis. Stuttgart: W. H. Freeman; 2000."},{"issue":"2","key":"1294_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s13238-010-0010-5","volume":"1","author":"J Wu","year":"2010","unstructured":"Wu J, Lu LY, Yu X. The role of BRCA1 in DNA damage response. Protein Cell. 2010;1(2):117\u201323.","journal-title":"Protein Cell"},{"issue":"5","key":"1294_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/GIM.0b013e3181d38f2f","volume":"12","author":"N Petrucelli","year":"2010","unstructured":"Petrucelli N, Daly MB, Feldman GL. Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2. Genet Med. 2010;12(5):245\u201359.","journal-title":"Genet Med"},{"key":"1294_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.21037\/atm.2016.12.76","volume":"5","author":"G Lippi","year":"2017","unstructured":"Lippi G, Mattiuzzi C, Montagnana M. BRCA population screening for predicting breast cancer: for or against? Ann Transl Med. 2017;5:13.","journal-title":"Ann Transl Med"},{"key":"1294_CR6","doi-asserted-by":"publisher","DOI":"10.15761\/ICST.1000228","author":"I Godet","year":"2017","unstructured":"Godet I, Gilkes DM. BRCA1 and BRCA2 mutations and treatment strategies for breast cancer. Integr Cancer Sci Ther. 2017. \n                    https:\/\/doi.org\/10.15761\/ICST.1000228\n                    \n                  .","journal-title":"Integr Cancer Sci Ther"},{"key":"1294_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2632917","author":"MM Hassan","year":"2016","unstructured":"Hassan MM, et al. Bioinformatics approach for prediction of functional coding\/noncoding simple polymorphisms (SNPs\/indels) in human BRAF gene. Adv Bioinf. 2016. \n                    https:\/\/doi.org\/10.1155\/2016\/2632917\n                    \n                  .","journal-title":"Adv Bioinf"},{"issue":"66","key":"1294_CR8","doi-asserted-by":"crossref","first-page":"110635","DOI":"10.18632\/oncotarget.22372","volume":"8","author":"N Deng","year":"2017","unstructured":"Deng N, et al. Single nucleotide polymorphisms and cancer susceptibility. Oncotarget. 2017;8(66):110635\u201349.","journal-title":"Oncotarget"},{"issue":"1","key":"1294_CR9","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/nar\/28.1.352","volume":"28","author":"EM Smigielski","year":"2000","unstructured":"Smigielski EM, et al. dbSNP: a database of single nucleotide polymorphisms. Nucleic Acids Res. 2000;28(1):352\u20135.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"1294_CR10","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/ejhg.2011.100","volume":"19","author":"JC Thery","year":"2011","unstructured":"Thery JC, et al. Contribution of bioinformatics predictions and functional splicing assays to the interpretation of unclassified variants of the BRCA genes. Eur J Hum Genet. 2011;19(10):1052\u20138.","journal-title":"Eur J Hum Genet"},{"issue":"12","key":"1294_CR11","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.3390\/ijms17122145","volume":"17","author":"MV Esposito","year":"2016","unstructured":"Esposito MV, et al. A novel pathogenic BRCA1 splicing variant produces partial intron retention in the mature messenger RNA. Int J Mol Sci. 2016;17(12):2145.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1294_CR12","first-page":"1","volume":"29","author":"I L\u00f3pez de Silanes","year":"2007","unstructured":"L\u00f3pez de Silanes I, Paz Quesada M, Esteller M. Aberrant regulation of messenger RNA 3 and M. Esteller, r Intron Retention. Cell Oncol. 2007;29(1):1\u201317.","journal-title":"Cell Oncol"},{"issue":"24","key":"1294_CR13","doi-asserted-by":"publisher","first-page":"9422","DOI":"10.1158\/0008-5472.CAN-09-2236","volume":"69","author":"P Singh","year":"2009","unstructured":"Singh P, et al. Global changes in processing of mRNA 3\u2032 untranslated regions characterize clinically distinct cancer subtypes. Cancer Res. 2009;69(24):9422\u201330.","journal-title":"Cancer Res"},{"issue":"6","key":"1294_CR14","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1074\/jbc.M709276200","volume":"283","author":"G Mao","year":"2008","unstructured":"Mao G, Pan X, Gu L. Evidence that a mutation in the MLH1 3\u2032-untranslated region confers a mutator phenotype and mismatch repair deficiency in patients with relapsed leukemia. J Biol Chem. 2008;283(6):3211\u20136.","journal-title":"J Biol Chem"},{"issue":"1","key":"1294_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/humu.22918","volume":"37","author":"I Karbassi","year":"2016","unstructured":"Karbassi I, et al. A standardized DNA variant scoring system for pathogenicity assessments in mendelian disorders. Hum Mutat. 2016;37(1):127\u201334.","journal-title":"Hum Mutat"},{"key":"1294_CR16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/1471-2407-14-421","volume":"14","author":"JJ Dorairaj","year":"2014","unstructured":"Dorairaj JJ, et al. A germline mutation in the BRCA1 3\u2032 UTR predicts stage IV breast cancer. BMC Cancer. 2014;14:421.","journal-title":"BMC Cancer"},{"issue":"12","key":"1294_CR17","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1002\/humu.22159","volume":"33","author":"BL Brewster","year":"2012","unstructured":"Brewster BL, et al. Identification of fifteen novel germline variants in the BRCA1 3\u2032 UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site. Hum Mutat. 2012;33(12):1665\u201375.","journal-title":"Hum Mutat"},{"issue":"5","key":"1294_CR18","doi-asserted-by":"publisher","first-page":"R71","DOI":"10.1186\/bcr1780","volume":"9","author":"S Gochhait","year":"2007","unstructured":"Gochhait S, et al. Implication of BRCA2-26G>A 5\u2032 untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53 codon 72 Arg\u2009>\u2009Pro polymorphism. Breast Cancer Res. 2007;9(5):R71.","journal-title":"Breast Cancer Res"},{"issue":"2","key":"1294_CR19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ajhg.2018.07.002","volume":"103","author":"DGR Evans","year":"2018","unstructured":"Evans DGR, et al. A dominantly inherited 5\u2032 UTR variant causing methylation-associated silencing of BRCA1 as a cause of breast and ovarian cancer. Am J Hum Genet. 2018;103(2):213\u201320.","journal-title":"Am J Hum Genet"},{"key":"1294_CR20","doi-asserted-by":"publisher","first-page":"W452","DOI":"10.1093\/nar\/gks539","volume":"40","author":"NL Sim","year":"2012","unstructured":"Sim NL, et al. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 2012;40:W452\u20137.","journal-title":"Nucleic Acids Res"},{"key":"1294_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2174\/1874220301401010031","volume":"2","author":"A Zick","year":"2015","unstructured":"Zick A, et al. A BRCA1 frame shift mutation in women of Kurdish Jewish descent. Open Med J. 2015;2:31\u20136.","journal-title":"Open Med J"},{"issue":"2","key":"1294_CR22","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1053\/j.semperi.2009.12.006","volume":"34","author":"JM Benson","year":"2010","unstructured":"Benson JM, Therrell BL Jr. History and current status of newborn screening for hemoglobinopathies. Semin Perinatol. 2010;34(2):134\u201344.","journal-title":"Semin Perinatol"},{"issue":"4","key":"1294_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1089\/gte.1998.2.271","volume":"2","author":"F Kaplan","year":"1998","unstructured":"Kaplan F. Tay\u2013Sachs disease carrier screening: a model for prevention of genetic disease. Genet Test. 1998;2(4):271\u201392.","journal-title":"Genet Test"},{"issue":"2","key":"1294_CR24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/03630260701297204","volume":"31","author":"G Bozkurt","year":"2007","unstructured":"Bozkurt G. Results from the north cyprus thalassemia prevention program. Hemoglobin. 2007;31(2):257\u201364.","journal-title":"Hemoglobin"},{"issue":"2","key":"1294_CR25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.soncn.2015.02.007","volume":"31","author":"J Lynch","year":"2015","unstructured":"Lynch J, Venne V, Berse B. Genetic tests to identify risk for breast cancer. Semin Oncol Nurs. 2015;31(2):100\u20137.","journal-title":"Semin Oncol Nurs"},{"issue":"12","key":"1294_CR26","doi-asserted-by":"publisher","first-page":"e1007752","DOI":"10.1371\/journal.pgen.1007752","volume":"14","author":"MS Cline","year":"2018","unstructured":"Cline MS, et al. BRCA challenge: BRCA exchange as a global resource for variants in BRCA1 and BRCA2. PLoS Genet. 2018;14(12):e1007752.","journal-title":"PLoS Genet"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-019-1294-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-019-1294-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-019-1294-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T23:53:12Z","timestamp":1593647592000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-019-1294-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,3]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["1294"],"URL":"https:\/\/doi.org\/10.1007\/s12032-019-1294-9","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,3]]},"assertion":[{"value":"20 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors certify that they have no affiliations with or involvement in any organisation or entity with any financial or non-financial interest in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"71"}}